In patients aged 15–35 years, 29% had drug-resistant virus, compared with 42% of those aged >35 years, although this difference did not reach statistical significance.
← all excerpts
Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa.
1
—
—